Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil with Apixaban in Pulmonary Embolism
NCT02946944Phase 1Unknown
- Sponsor
- E. Meshalkin National Medical Research Centre
- Start
- Oct 2016
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of sildenafil in pulmonary embolism (PE) (2 arms), sponsored by E. Meshalkin National Medical Research Centre. Primary endpoint: MSCT Right Ventricular/Left Ventricular Index at 7 days. Status: unknown.
02
Drugs
sildenafil
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT02946944.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02946944.